[X]
|
ANNUAL
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
For
the fiscal year ended December 31, 2006
|
|
OR
|
|
[
]
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
Delaware
|
06-1059331
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
incorporation
or organization)
|
Identification
No.)
|
Two
Liberty Place, Philadelphia, Pennsylvania
|
19192
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Name
of each exchange on
|
|
Title
of each class
|
which
registered
|
Common
Stock, Par Value $0.25
|
New
York Stock Exchange, Inc.
|
Preferred
Stock
|
|
Purchase
Rights
|
It
|
|||
•
|
Health
Care
|
•
|
Disability
and Life
|
•
|
International
|
•
|
Other
Operations
|
•
|
Run-off
Retirement
|
•
|
Run-off
Reinsurance
|
•
|
acquired
the voluntary health insurance business of Star-HRGSM;
|
•
|
transitioned
business from a health care industry competitor in the Arizona market;
|
•
|
entered
into strategic alliances with several regional managed care organizations
including Tufts Health Plan, HealthPartners, Inc., Health Alliance
Plan,
and MVP Health Plan;
|
•
|
acquired
vielife Holdings, a U.K. based provider of integrated online health
management and coaching programs;
|
•
|
negotiated
to acquire Mid-South Administrative Group, LLC, a Memphis, Tennessee-based
company that designs and administers self-funded health care benefits
(and
acquired the company on January 1, 2007);
and
|
•
|
entered
into an agreement with the University of Michigan in order to access
certain intellectual property related to identification of health
risks
and employer worksite health and wellness
programs.
|
•
|
Custom
Network Solutions, introduced on January 1, 2006, which gives employers
the ability to select four different provider network options to
meet the
specific needs of their plan participants;
and
|
•
|
customized
on-line self-assessment and help tools for a variety of concerns,
including stress, grief, relationship issues and depression, that
connect
consumers to a telephonic or face-to-face counselor as
appropriate.
|
•
|
a
prescription drug price comparison tool that gives members price
comparisons on branded and generic drugs from pharmacy retailers
and mail
order, showing out-of-pocket as well as total anticipated costs,
of the
prescription;
|
•
|
DrugCompare
and Medication Library where members can obtain detailed information
and
comparisons of medications; and
|
•
|
Prescription
Claim History Tool, which enables consumers to see their combined
retail
and home delivery prescription history to help plan for and track
out-of-pocket expenses.
|
•
|
early
intervention by CIGNA's network of over 2,500 clinical
professionals;
|
•
|
targeted
outreach using CIGNA's predictive modeling capabilities through tools
such
as the CIGNA Health Advisor Portal;
|
•
|
the
integration of medical, disability and specialty (pharmacy, dental
and
behavioral) care to help with consistent case management; and
|
•
|
disease
management programs, including CIGNA Well Aware for Better
Health®,
which focuses on chronic conditions such as asthma, diabetes, heart
disease, low back pain, depression, weight complications, chronic
obstructive pulmonary disease, and other targeted conditions.
|
•
|
myCIGNA.com,
CIGNA’s
consumer Internet portal. The portal is personalized with each member’s
CIGNA medical, dental and pharmacy plan information;
|
•
|
myCignaPlans.com,
a website which allows prospective members to compare plan coverage
and
pricing options, before enrolling, based on a variety of factors.
The
application gives consumers information on the total health care
cost to
them and their employer;
|
•
|
a
number of interactive online cost and quality information tools that
compare hospital quality and efficiency information, prescription
drug
choices and average price estimates and member-specific average
out-of-pocket costs estimates for certain medical procedures;
and
|
•
|
Health
Risk Assessment, an online interactive tool through which consumers
can
identify potential health risks and monitor their health status.
|
•
|
national
accounts, which are multi-site employers with more than 5,000
employees;
|
•
|
regional
accounts, which are generally defined as multi-site employers with
more
than 50 but fewer than 5,000
employees;
|
•
|
small
business and individual, which includes employers with fewer than
50
employees and individuals;
|
•
|
government,
which includes employees
in federal, state and local governments, primary and secondary schools,
and colleges and universities;
|
•
|
Taft-Hartley,
which includes members
covered by union trust funds;
|
•
|
seniors,
which focuses on the health care needs of individuals 55 years and
older;
and
|
•
|
emerging,
which includes the voluntary segment enhanced through the acquisition
of
Star HRG
SM.
|
•
|
other
large insurance companies that provide group health and life insurance
products;
|
•
|
Blue
Cross and Blue Shield
organizations;
|
•
|
stand-alone
HMOs and PPOs;
|
•
|
HMOs
affiliated with major insurance companies and hospitals;
and
|
•
|
national
managed pharmacy, behavioral health and cost containment services
companies.
|
Year
Ended
December
31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
(In
millions)
|
||||||||||
Life
|
$
|
1,050
|
$
|
1,108
|
$
|
1,041
|
||||
Disability
|
798
|
677
|
617
|
|||||||
Other
|
260
|
280
|
265
|
|||||||
Total
Premiums and
Fees
|
$
|
2,108
|
$
|
2,065
|
$
|
1,923
|
Year
Ended December 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
(In
millions)
|
||||||||||
Life,
Accident and Supplemental Health Insurance
|
$
|
824
|
$
|
677
|
$
|
545
|
||||
International
Health Care Benefits
|
702
|
566
|
481
|
|||||||
Total
Premiums and
Fees
|
$
|
1,526
|
$
|
1,243
|
$
|
1,026
|
•
|
deferred
gains recognized from the 1998 sale of the individual life insurance
and
annuity business;
|
•
|
corporate
life insurance (including policies on which loans are outstanding);
and
|
•
|
settlement
annuity business.
|
•
|
$4.6
billion in separate account assets that are managed by the buyer
of the
retirement benefits business pursuant to modified coinsurance
arrangements; and
|
•
|
$4.0
billion in funds which support certain corporate owned life insurance,
health care and disability and life products.
|
•
|
the
form and content of customer contracts including benefit mandates
(including special requirements for small groups of generally under
50
employees);
|
•
|
premium
rates;
|
•
|
the
content of agreements with participating providers of covered
services;
|
•
|
producer
appointment and compensation;
|
•
|
claims
processing and appeals;
|
•
|
solvency
requirements;
|
•
|
underwriting
practices;
|
•
|
reinsurance
arrangements;
|
•
|
advertising
practices;
|
•
|
unfair
trade and claim practices;
|
•
|
delegation
of administrative functions;
|
•
|
risk
sharing arrangements with
providers;
|
•
|
use
and disclosure of individuals’ identifiable information;
and
|
•
|
operation
of consumer-driven plans (including health savings accounts, health
reimbursement accounts and flexible spending
accounts).
|
•
|
those
offering individual and group Medicare Advantage (HMO) coverage in
Arizona;
|
•
|
contractual
arrangements with the federal government for the processing of certain
Medicare claims and other administrative
services;
|
•
|
contractual
arrangements with the federal government to provide disease management
services to chronically ill Medicare beneficiaries in the state of
Georgia; and
|
•
|
those
offering Medicare Pharmacy (Part D) products that are subject to
federal
Medicare regulations.
|
CG
Life
|
|
Insurance
Ratings(1)
|
|
A.M.
Best
|
A
|
(“Excellent,”
|
|
3rd
of
16)
|
|
Moody’s
|
A2
|
(“Good,”
|
|
6th
of
21)
|
|
S&P
|
A-
|
(“Strong,”
|
|
7th
of
21)
|
|
Fitch
|
A
|
(“Strong,”
|
|
6th
of
24)
|
(1)
|
Includes
the rating assigned, the agency’s characterization of the rating and the
position of the rating in the agency’s rating scale (e.g., CG Life’s
rating by A.M. Best is the 3rd highest rating awarded in its scale
of
16).
|
•
|
Moody’s,
Aaa to C (“Exceptional” to
“Lowest”);
|
•
|
S&P,
AAA to D (“Extremely Strong” to “Default”);
and
|
•
|
Fitch,
AAA to D (“Highest” to “Default”).
|
•
|
Moody’s,
Prime-1 to Not Prime (“Superior” to “Not
Prime”);
|
•
|
S&P,
A-1+ to D (“Extremely Strong” to “Default”);
and
|
•
|
Fitch,
F-1+ to D (“Very Strong” to
“Distressed”).
|
Commercial
|
||
Senior
Debt
|
Paper
|
|
Moody’s
|
Baa2
|
P2
|
(“Adequate,”
|
(“Strong,”
|
|
9th
of
21)
|
2nd
of
4)
|
|
S&P
|
BBB
|
A2
|
(“Adequate,”
|
(“Good,”
|
|
9th of
22)
|
3rd
of
7)
|
|
Fitch
|
BBB
|
F2
|
(“Good,”
9th
of
24)
|
(“Moderately
Strong,”
3rd
of
7)
|
· |
the
ability to gain and retain customers and members by providing appropriate
levels of support and service for CIGNA’s products, as well as avoiding
service and health advocacy related
errors;
|
· |
the
ability to attract and retain sufficient numbers of qualified employees;
|
· |
the
negotiation of favorable provider
contracts;
|
· |
CIGNA's
ability to develop and introduce new products or programs, because
of the
inherent risks and uncertainties associated with product development,
particularly in response to government regulation or the increased
focus
on consumer directed products;
|
· |
the
identification and introduction of the proper mix or integration
of
products that will be accepted by the marketplace; and
|
· |
the
ability of CIGNA’s products and services to differentiate CIGNA from its
competitors and for CIGNA to demonstrate that these products and
services
(such as disease management and health advocacy programs, provider
credentialing and other quality care initiatives) result in improved
health outcomes and reduced costs.
|
CG
Life
|
|
Insurance
Ratings(1)
|
|
A.M.
Best
|
A
|
(“Excellent,”
|
|
3rd
of
16)
|
|
Moody’s
|
A2
|
(“Good,”
|
|
6th
of
21)
|
|
S&P
|
A-
|
(“Strong,”
|
|
7th
of
21)
|
|
Fitch
|
A
|
(“Strong,”
|
|
6th
of
24)
|
Issuer
Purchases of Equity Securities
|
||||
Period
|
Total
# of
Shares
purchased(1)
|
Average
price
paid
per share
|
Total
# of shares
purchased
as part of
publicly
announced
program
(2)
|
Approximate
dollar
value
of shares that may yet be purchased
as
part of publicly
announced
program
(3)
|
October
1-31, 2006
|
1,802,351
|
$118.43
|
1,801,900
|
$820,616,299
|
November
1-30, 2006
|
1,309,007
|
$121.92
|
1,308,500
|
$661,084,332
|
December
1-31, 2006
|
1,353,950
|
$129.85
|
1,353,800
|
$485,287,708
|
Total
|
4,465,308
|
$122.92
|
4,464,200
|
N/A
|
(1) |
Includes
shares tendered by employees as payment of the exercise price of
stock
options granted under the Company’s equity compensation plans. Employees
tendered 451
shares in October, 507
shares in November and 150
shares in December.
|
(2) |
CIGNA
has had a repurchase program for many years, and has had varying
levels of
repurchase authority and activity under this program. The program
has no
expiration date. CIGNA suspends activity under this program from
time to
time, generally without public announcement. Remaining authorization
under
the program was approximately $485
million as of December 31, 2006. CIGNA has, and may continue from
time to
time, to effect open market purchases through 10b5-1 plans, which
allows a
company to repurchase its shares at times when it otherwise might
be
prevented from doing so under insider trading laws or because of
self-imposed trading blackout
periods.
|
(3) |
Approximate
dollar value of shares is as of the last date of the applicable
month.
|
CIGNA
CORPORATION
|
|
By:
/s/
Michael
W. Bell
|
|
Michael
W. Bell
|
|
Executive
Vice President and
|
|
Chief
Financial Officer
|
|
(Principal
Financial Officer)
|
Signature
|
Title
|
|
/s/
H.
Edward Hanway
|
||
H.
Edward Hanway
|
Chairman,
Chief Executive Officer and Director
(Principal
Executive Officer)
|
|
/s/
Annmarie
T. Hagan
|
||
Annmarie
T. Hagan
|
Vice
President and Chief Accounting Officer
(Principal
Accounting Officer)
|
|
/s/
Robert
H. Campbell
|
||
Robert
H. Campbell
|
Director
|
|
/s/
Isaiah
Harris, Jr.
|
||
Isaiah
Harris, Jr.
|
Director
|
|
/s/
Jane
E. Henney, M.D.
|
||
Jane
E. Henney, M.D.
|
Director
|
|
|
||
/s/
Peter
N. Larson
|
||
Peter
N. Larson
|
Director
|
/s/
Roman
Martinez IV
|
||
Roman
Martinez IV
|
Director
|
|
/s/
Harold
A. Wagner
|
||
Harold
A. Wagner
|
Director
|
|
/s/
Carol
Cox Wait
|
||
Carol
Cox Wait
|
Director
|
|
/s/
Donna
F. Zarcone
|
||
Donna
F. Zarcone
|
Director
|
|
/s/
William
D. Zollars
|
||
William
D. Zollars
|
Director
|
PAGE
|
|||
Schedules
|
|||
Type
of Investment
|
Cost
|
Fair
Value
|
Amount
at which
shown
in the consolidated
balance
sheet
|
|||||||
Fixed
maturities:
|
||||||||||
Bonds:
|
||||||||||
United
States government and government
|
||||||||||
agencies
and authorities
|
$
|
356
|
$
|
597
|
$
|
597
|
||||
States,
municipalities and political subdivisions
|
2,360
|
2,488
|
2,488
|
|||||||
Foreign
governments
|
853
|
918
|
918
|
|||||||
Public
utilities
|
782
|
812
|
812
|
|||||||
All
other corporate bonds
|
6,307
|
6,556
|
6,556
|
|||||||
Asset-backed
securities:
|
||||||||||
United
States government agencies,
|
||||||||||
mortgage-backed
|
2
|
3
|
3
|
|||||||
Other
mortgage-backed
|
217
|
222
|
222
|
|||||||
Other
asset-backed
|
452
|
515
|
515
|
|||||||
Redeemable
preferred stocks
|
44
|
44
|
44
|
|||||||
Total
fixed maturities
|
11,373
|
12,155
|
12,155
|
|||||||
Equity
securities:
|
||||||||||
Common
stocks:
|
||||||||||
Industrial,
miscellaneous and all other
|
9
|
24
|
24
|
|||||||
Public
utilities
|
--
|
--
|
--
|
|||||||
Non-redeemable
preferred stocks
|
103
|
107
|
107
|
|||||||
Total
equity securities
|
112
|
131
|
131
|
|||||||
Mortgage
loans on real estate
|
3,988
|
3,988
|
||||||||
Policy
loans
|
1,405
|
1,405
|
||||||||
Real
estate investments
|
117
|
117
|
||||||||
Other
long-term investments
|
418
|
418
|
||||||||
Short-term
investments
|
89
|
89
|
||||||||
Total
investments
|
$
|
17,502
|
$
|
18,303
|
||||||
For
the year ended
December
31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
Other
revenues
|
$
|
2
|
$
|
7
|
$
|
6
|
||||
Total
revenues
|
2
|
7
|
6
|
|||||||
Operating
expenses:
|
||||||||||
Interest
|
101
|
105
|
107
|
|||||||
Intercompany
interest
|
277
|
162
|
73
|
|||||||
Other
|
90
|
71
|
138
|
|||||||
Total
operating expenses
|
468
|
338
|
318
|
|||||||
Loss
before income taxes
|
(466
|
)
|
(331
|
)
|
(312
|
)
|
||||
Income
tax benefit
|
(166
|
)
|
(126
|
)
|
(138
|
)
|
||||
Loss
of parent company
|
(300
|
)
|
(205
|
)
|
(174
|
)
|
||||
Equity
in income of subsidiaries from
continuing
operations
|
1,459
|
1,481
|
1,751
|
|||||||
Income
from continuing operations
|
1,159
|
1,276
|
1,577
|
|||||||
Income
(Loss) from discontinued operations, net of taxes
|
(4
|
)
|
349
|
--
|
||||||
Income
before Cumulative Effect of Accounting Change
|
1,155
|
1,625
|
1,577
|
|||||||
Cumulative
Effect of Accounting Change, net of taxes
|
--
|
--
|
(139
|
)
|
||||||
Net
income
|
$
|
1,155
|
$
|
1,625
|
$
|
1,438
|
||||
As
of December 31,
|
|||||||||||||
2006
|
2005
|
||||||||||||
Assets:
|
|||||||||||||
Cash
and cash equivalents
|
$
|
13
|
$
|
1
|
|||||||||
Investments
in subsidiaries
|
11,932
|
12,204
|
|||||||||||
Other
assets
|
538
|
510
|
|||||||||||
Total
assets
|
$
|
12,483
|
$
|
12,715
|
|||||||||
Liabilities:
|
|||||||||||||
Intercompany
|
$
|
5,498
|
$
|
4,711
|
|||||||||
Current
portion of long-term debt
|
376
|
100
|
|||||||||||
Long-term
debt
|
1,198
|
1,324
|
|||||||||||
Other
liabilities
|
1,081
|
1,220
|
|||||||||||
Total
liabilities
|
8,153
|
7,355
|
|||||||||||
Shareholders'
Equity:
|
|||||||||||||
Common
stock (shares issued, 160; 160)
|
40
|
40
|
|||||||||||
Additional
paid-in capital
|
2,451
|
2,385
|
|||||||||||
Net
unrealized appreciation —
fixed maturities
|
$
|
187
|
$
|
195
|
|||||||||
Net
unrealized appreciation —
equity securities
|
22
|
24
|
|||||||||||
Net
unrealized depreciation — derivatives
|
(15
|
)
|
(14
|
)
|
|||||||||
Net
translation of foreign currencies
|
33
|
2
|
|||||||||||
Postretirement
benefits liability adjustment
|
(396
|
)
|
-
|
||||||||||
Minimum
pension liability adjustment
|
-
|
(716
|
)
|
||||||||||
Accumulated
other comprehensive loss
|
(169
|
)
|
(509
|
)
|
|||||||||
Retained
earnings
|
6,177
|
5,162
|
|||||||||||
Less
treasury stock, at cost
|
(4,169
|
)
|
(1,718
|
)
|
|||||||||
Total
shareholders' equity
|
4,330
|
5,360
|
|||||||||||
Total
liabilities and shareholders' equity
|
$
|
12,483
|
$
|
12,715
|
|||||||||
For
the year ended
December
31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
Cash
Flows from Operating Activities:
|
||||||||||
Net
Income
|
$
|
1,155
|
$
|
1,625
|
$
|
1,438
|
||||
Adjustments
to reconcile net income
to net cash provided by operating activities:
|
||||||||||
Equity in income of subsidiaries
|
(1,459
|
)
|
(1,481
|
)
|
(1,751
|
)
|
||||
(Income) loss from discontinued operations
|
4
|
(349
|
)
|
--
|
||||||
Cumulative
effect of accounting change, net of taxes
|
--
|
--
|
139
|
|||||||
Dividends
received from subsidiaries
|
1,745
|
1,306
|
499
|
|||||||
Other
liabilities
|
347
|
(290
|
)
|
106
|
||||||
Cash
provided by operating activities of discontinued operations
|
--
|
222
|
--
|
|||||||
Other,
net
|
(172
|
)
|
(68
|
)
|
(10
|
)
|
||||
Net
cash provided by operating activities
|
1,620
|
965
|
421
|
|||||||
Cash
Flows from Investing Activities:
|
||||||||||
Other,
net
|
(15
|
)
|
(9
|
)
|
5
|
|||||
Net
cash provided by (used in) investing activities
|
(15
|
)
|
(9
|
)
|
5
|
|||||
Cash
Flows from Financing Activities:
|
||||||||||
Net
change in intercompany debt
|
787
|
327
|
364
|
|||||||
Net
proceeds on issuance of long-term debt
|
246
|
--
|
--
|
|||||||
Repayment
of long-term debt
|
(100
|
)
|
--
|
(76
|
)
|
|||||
Issuance
of common stock
|
251
|
346
|
64
|
|||||||
Common
dividends paid
|
(12
|
)
|
(13
|
)
|
(100
|
)
|
||||
Repurchase
of common stock
|
(2,765
|
)
|
(1,618
|
)
|
(676
|
)
|
||||
Net
cash used in financing activities
|
(1,593
|
)
|
(958
|
)
|
(424
|
)
|
||||
Net
increase (decrease) in cash and cash equivalents
|
12
|
(2
|
)
|
2
|
||||||
Cash
and cash equivalents, beginning of year
|
1
|
3
|
1
|
|||||||
Cash
and cash equivalents, end of year
|
$
|
13
|
$
|
1
|
$
|
3
|
||||
(In millions)
|
2006
|
|
2005
|
||||
Short-term:
|
|||||||
Current
maturities of long-term debt
|
$
|
376
|
$
|
100
|
|||
Total
short-term debt
|
$
|
376
|
$
|
100
|
|||
Long-term:
|
|||||||
Uncollateralized
debt:
|
|||||||
7.4%
Notes due 2007
|
$
|
-
|
$
|
291
|
|||
8
¼% Notes due 2007
|
-
|
85
|
|||||
7%
Notes due 2011
|
222
|
222
|
|||||
6.375%
Notes due 2011
|
226
|
226
|
|||||
7.65%
Notes due 2023
|
100
|
100
|
|||||
8.3%
Notes due 2023
|
17
|
17
|
|||||
7
7/8% Debentures due 2027
|
300
|
300
|
|||||
8.3%
Step Down Notes due 2033
|
83
|
83
|
|||||
6.15%
Notes due 2036
|
250
|
-
|
|||||
Total
long-term debt
|
$
|
1,198
|
$
|
1,324
|
· |
CIGNA
Corporation has arranged for bank letters of credit in support
of CIGNA
Global Reinsurance Company, an indirect wholly owned subsidiary
domiciled
in Bermuda, in the amount of $78 million. These letters of
credit secure
the payment of insureds’ claims from run-off reinsurance operations. CIGNA
Corporation has agreed to indemnify the banks providing the
letters of
credit in the event of any draw. As of December 31, 2006 approximately
$75
million of the letters of credit are
issued.
|
· |
CIGNA
Corporation has provided a capital commitment deed in an amount
up to $185
million in favor of CIGNA Global Reinsurance Company. This
deed is equal
to the letters of credit securing the payment of insureds’ claims from
run-off reinsurance operations. This deed is required by Bermuda
regulators to have these letters of credit for the London run-off
reinsurance operations included as admitted
assets.
|
· |
Various
indirect, wholly owned subsidiaries have obtained surety bonds
in the
normal course of business. If there is a claim on a surety
bond and the
subsidiary is unable to pay, CIGNA Corporation guarantees payment
to the
company issuing the surety bond. The aggregate amount of such
surety bonds
as of December 31, 2006 was $50
million.
|
· |
CIGNA
Corporation is obligated under a $25 million letter of credit
required by
the insurer of its high-deductible self-insurance programs
to indemnify
the insurer for claim liabilities that fall within deductible
amounts for
policy years dating back to 1994.
|
· |
CIGNA
Corporation also provides solvency guarantees aggregating $34
million
under state and federal regulations in support of its indirect
wholly
owned medical HMOs in several states.
|
· |
CIGNA
Corporation has arranged a $150 million letter of credit in
support of
CIGNA Europe Insurance Company, an indirect wholly owned subsidiary.
CIGNA
Corporation has agreed to indemnify the banks providing the
letters of
credit in the event of any draw. CIGNA Europe Insurance Company
is the
holder of the letters of credit.
|
· |
In
addition, CIGNA Corporation has agreed to indemnify payment
of losses
included in CIGNA Europe Insurance Company’s reserves on the reinsurance
business transferred from ACE. As of December 31, 2006, the
reserve was
$389 million.
|
Segment
|
Deferred
policy
acquisition
costs
|
Future
policy
benefits
and
contractholder
deposit
funds
|
Medical
claims
payable
and
unpaid
claims
|
|||||||
Year
Ended December 31, 2006:
|
||||||||||
Health
Care
|
$
|
37
|
$
|
617
|
$
|
1,221
|
||||
Disability
and Life
|
10
|
828
|
2,954
|
|||||||
International
|
579
|
976
|
204
|
|||||||
Run-off
Retirement
|
--
|
2,542
|
--
|
|||||||
Run-off
Reinsurance
|
--
|
890
|
746
|
|||||||
Other
Operations
|
81
|
11,684
|
145
|
|||||||
Corporate
|
--
|
--
|
--
|
|||||||
Total
|
$
|
707
|
$
|
17,537
|
$
|
5,270
|
||||
Year
Ended December 31, 2005:
|
||||||||||
Health
Care
|
$
|
27
|
$
|
794
|
$
|
1,478
|
||||
Disability
and Life
|
12
|
973
|
2,835
|
|||||||
International
|
491
|
870
|
171
|
|||||||
Run-off
Retirement
|
--
|
2,808
|
1
|
|||||||
Run-off
Reinsurance
|
--
|
980
|
826
|
|||||||
Other
Operations
|
88
|
11,877
|
135
|
|||||||
Corporate
|
--
|
--
|
--
|
|||||||
Total
|
$
|
618
|
$
|
18,302
|
$
|
5,446
|
||||
Year
Ended December 31, 2004:
|
||||||||||
Health
Care
|
$
|
26
|
$
|
857
|
$
|
1,941
|
||||
Disability
and Life
|
12
|
1,022
|
2,796
|
|||||||
International
|
420
|
746
|
146
|
|||||||
Run-off
Retirement
|
--
|
10,203
|
--
|
|||||||
Run-off
Reinsurance
|
--
|
1,016
|
894
|
|||||||
Other
Operations
|
86
|
12,228
|
144
|
|||||||
Corporate
|